Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending
Biologics
Clinical Development
Ophthalmology
Cell & Gene Therapy
Fierce 50
Special Report
Awards Gala
Awards
Outsourcing Awards
Innovation Awards
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Cancer diagnostics
MedTech
Guardant hits the road with colon cancer blood test
Guardant Health is taking its Shield blood test on the road in hopes of tackling “dangerously low” bowel cancer screening rates.
Natalie Missakian
Mar 5, 2026 5:50am
Nvidia dives deep into cancer research with Droplet Biosciences
Mar 4, 2026 8:40am
Grail stock craters as Galleri trial fails to hit endpoint
Feb 20, 2026 7:30am
Optellum tapped by NHS for AI-powered lung cancer diagnostic
Feb 2, 2026 8:55am
Guardant Health gets FDA nod to expand test for colon cancer
Jan 26, 2026 8:15am
Labcorp adds to its suite of tests to detect cancer recurrence
Jan 13, 2026 9:45am
